VELOXIS PHARMACEUTICALS A/S: Financial statements 2021
CVR: 26527767
Source: annual report 2021, Danish Business Authority
01/04/2020 – 31/03/2021
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2021. In 2021, the company reported revenue of USD 45,335,000 and a net result of USD 1,057,461,000. The profit margin was 2,332.5%. Equity in the 2021 report amounted to USD 1,303,915,000. The solvency ratio was 100%.
- Revenue
- USD 45,335,000
- Gross Profit
- USD 45,335,000
- Profit/Loss
- USD 1,057,461,000
- Equity
- USD 1,303,915,000
- Total Assets
- USD 1,304,141,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 45.3M USD | 45.3M USD | 1.1B USD | 1.3B USD | - |
| 2018 | 39.5M USD | 31.6M USD | -5.3M USD | 4.6M USD | - |
| 2017 | 30.2M USD | 25M USD | -9.5M USD | 5.3M USD | - |
| 2016 | 9.2M USD | 6.2M USD | -10.1M USD | 10.2M USD | - |
| 2015 | 14.2M | -989K | -176.1M | 89.7M | - |
Official annual report
Find more companies like VELOXIS PHARMACEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 8, 2021, Mark Earl Hensley is registered as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
As of November 8, 2021, Craig Alexander Collard has stepped down as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
As of November 8, 2021, Ira Duarte has stepped down as director of VELOXIS PHARMACEUTICALS A/S.
As of April 14, 2021, Hideo Hikami has joined the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of April 14, 2021, Hiroki Ideguchi has joined the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of April 14, 2021, Masaya Etoh has left the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of April 14, 2021, Matthew Ryan Dumont has left the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of January 4, 2021, is registered as an owner of VELOXIS PHARMACEUTICALS A/S with an ownership share of 100%.
About VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.
